Halozyme Therapeutics, Inc. (HALO)
67.23
-0.13
(-0.19%)
USD |
NASDAQ |
Mar 06, 10:25
Halozyme Therapeutics Price : 67.23 for March 6, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Merck & Co., Inc. | 114.40 |
| Johnson & Johnson | 236.25 |
| Skye Bioscience, Inc. | 0.7203 |
| AIM ImmunoTech, Inc. | 0.6926 |
| Stryker Corp. | 358.63 |
Price Related Metrics
| PE Ratio | 26.98 |
| PS Ratio | 5.907 |
| Price to Book Value | 162.54 |
| Price to Free Cash Flow | 12.80 |
| Earnings Yield | 3.71% |
| Market Cap | 7.934B |
| Operating PE Ratio | 10.11 |
| Normalized PE Ratio | 14.65 |